Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF549 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NRGN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GSTO1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ABCA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SERPINC1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DGKI - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BATF3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
METTL7A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MYLPF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SNX27 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SDC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TICAM1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ADH5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PTPN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GPR89A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ITGB3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NBAS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ABI2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TALDO1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPS21 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on